Table 2.
Differences in Baseline Laboratory Data and Medication Use Between Male and Female Cohorts
| Laboratory data | Male cohort (n=6387) | Female cohort (n=8325) | % of the cohort with the available test |
|---|---|---|---|
| Sodium level | 140±3.75 | 140±3.43 | 90 (62/69) |
| Potassium level | 4.32±0.52 | 4.19±0.531 | 90 (62/69) |
| Chloride level | 102±4.68 | 102±4.5 | 90 (61/68) |
| Bicarbonate level | 25.4±4.06 | 25.3±3.69 | 93 (43/46) |
| Urea nitrogen level | 18.4±11.4 | 14±8.07 | 75 (18/24) |
| Creatinine level | 1.32±1.43 | 0.908±0.83 | 92 (68/74) |
| Glucose level | 124±60 | 111±50.6 | 92 (68/74) |
| Calcium level | 9.2±0.68 | 9.3±0.62 | 88 (56/64) |
| Magnesium level | 1.96±0.36 | 2.02±0.66 | 100 (13/13) |
| Phosphate level | 3.31±1.03 | 3.39±0.86 | 94 (31/33) |
| Leukocyte level | 7.59±6.13 | 7.39±4.42 | 91 (68/75) |
| Hemoglobin level | 14.1±2.2 | 12.9±1.8 | 91 (67/74) |
| Platelet count | 226±84.3 | 256±81.5 | 91 (68/75) |
| Alanine aminotransferase level | 35±53.6 | 23.9±30.2 | 93 (66/71) |
| Aspartate aminotransferase level | 36.8±80.5 | 27.9±47.9 | 93 (65/70) |
| Alkaline phosphatase level | 82.6±58.3 | 80.1±46.3 | 92 (60/65) |
| Lactate dehydrogenase level | 316±225 | 279±220 | 108 (40/37) |
| Total bilirubin level | 0.654±0.51 | 0.488±0.44 | 93 (65/70) |
| Albumin level | 3.96±0.80 | 4.06±0.71 | 92 (60/65) |
| Troponin level | 0.685±8.45 | 0.139±0.81 | 120 (12/10) |
| B-type natriuretic peptide level | 227±613 | 191±563 | 113 (9/8) |
| N-terminal pro–B-type natriuretic peptide level | 3027±697 | 2562±735 | 120 (6/5) |
Data are presented as mean ± SD unless specified otherwise.